期刊文献+

血管活性肠肽真核表达质粒的构建及鉴定 被引量:5

Construction of recombinant plasmid containing mouse vasoactive intestinal peptide gene and its expression in COS-7 cells
下载PDF
导出
摘要 目的构建一种具有生物学活性的血管活性肠肽(VIP)的真核表达质粒。方法利用RT-PCR从小鼠胸腺淋巴细胞中克隆有信号肽序列的VIPcDNA,插入真核表达载体pcDNA3.1,构建含VIP的重组质粒pcDNA3.1-VIP,转染COS-7细胞,用ELISA和Westernblot鉴定表达的蛋白,细胞因子释放抑制法测定生物学活性。结果经酶切和基因测序证实,克隆的基因片段为带有信号肽序列的VIP基因;经转染的COS-7细胞表达VIP蛋白,并能有效地抑制巨噬细胞的TNF-α释放。结论成功构建了能够表达具有生物学活性的真核表达质粒pcDNA3.1-VIP。 Objective: To construct the eukaryotic expression plasmid containing mouse vasoactive intestinal peptide(VIP) gene with biological activities. Methods: VIP cDNA including the sequences of signal peptide was cloned from mouse thymus by RT-PCR,and then inserted into the mammalian expression vector pcDNA3.1 between Hind III and EcoR I restriction sites.COS-7 cells were transfected with pcDNA3.1-VIP using liposome,the expression of VIP was identified by Western blot and ELISA.Supernatant of transfected cell culture was added to LPS-stimulated macrophages and the TNF-αproduction in cell medium was observed by ELISA. Results: The cloned VIP cDNA was confirmed by enzyme digestion and DNA sequencing.The expression of VIP was detected in the pcDNA3.1-VIP transfected COS-7 cells by Western blot and ELISA.The VIP in culture supernatant potently inhibited TNF-αproduction by LPS-induced Macrophages in vitro. Conclusion: The eukaryotic expression plasmid that expresses biological active murine VIP has been constructed successfully. [
出处 《浙江大学学报(医学版)》 CAS CSCD 2005年第2期148-151,共4页 Journal of Zhejiang University(Medical Sciences)
基金 国家自然科学基金项目(30170874) 浙江省教育厅科研基金项目(20040232)
关键词 血管活性肠肽 质粒 克隆 分子 基因表达 Vasoactive intestinal peptide Plasmids Cloning,molecular Gene expression
  • 相关文献

参考文献8

  • 1VOICE J K,DORSAM G,CHAN R C,et al.Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide [J].Regul Pept,2002,109(1-3):199-208.
  • 2DELGADO M,GANEA D.Cutting edge:is vasoactive intestinal peptide a type 2 cytokine [J]?J Immunol,2001,166(5):2907-2912.
  • 3DELGADO M,ABAD C,MARTINEZ C,et al.Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease [J].Nat Med,2001,7(5):563-568.
  • 4TUNCEL N,TORE F,SAHINTURK V V,et al.Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells:a potential therapeutic strategy in controlling septic shock [J].Peptides,2000,21(1):81-89.
  • 5KEINO H,KEZUKA T,TAKEUCHI M,et al.Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide [J].Arch Ophthalmol,2004,122(8):1779-1784.
  • 6DELGADO M,POZO D,MARTINEZ C,et al.Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages:in vitro and in vivo studies [J].J Immunol,1999,162(4):2358-2367.
  • 7LODDE B M,DELPORTE C,GOLDSMITH C M,et al.A recombinant adenoviral vector encoding functional vasoactive intestinal peptide [J].Biochem Biophys Res Commun,2004,319(1):189-192.
  • 8HO S H,HAHN W,LEE H J,et al.Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4 [J].Biochem Biophys Res Commun,2004,321(4):759-766.

同被引文献49

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部